Artelo Biosciences Total Current Liabilities

Artelo Biosciences (ARTL) currently reports a total current liabilities of $5.8M as of March 2026. That compares with $2.8M in the prior-year period — up 107.8% year over year. Use the charts on this page to explore Artelo Biosciences's total current liabilities history and peer comparisons.

Artelo Biosciences's total current liabilities increased from $2.8M to $5.8M — a 107.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Artelo Biosciences reported $5.8M in total current liabilities as of March 2026. That compares with $2.8M in the prior-year period — up 107.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $5.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Artelo Biosciences, and consider following ARTL for alerts when major investors trade the stock.

Artelo Biosciences is classified in the Consumer Staples sector. On total current liabilities, it currently shows $5.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing ARTL with unrelated industries.